Immune disorder research

InteKrin Therapeutics is a clinical-stage, privately held BioPharma company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders. Diseases such as diabetes, metabolic syndrome, and...

Total money raised: $18.5M

94022 4300 El Camino Real, Suite 201

Los Altos
Los Altos

Phone: 650-941-5501

Updated on Jun 26, 2009
InteKrin at CrunchBase
Alex DePaoli Chief Medical Officer

August, 2008

InteKrin raised $18.5M in a Series C round from Amgen, Skyline Ventures, Sofinnova Ventures, OrbiMed Advisors, Asset Management Company, Sears Capital Management, and Vivo Ventures

InteKrin raises $18.5M for continued work on diabetes drug